Cianna Medical

What Cianna Medical does

Cianna Medical is a US-based women's health medical-device company founded in 2007 and headquartered in Aliso Viejo, California, focused on the diagnosis and treatment of early-stage breast cancer. The company developed a complementary oncology portfolio spanning three core products: SCOUT Radar Localization, a wire-free, radar-based tumor localization system that enables surgeons to precisely target affected tissue during breast and soft-tissue procedures; SAVI Brachy, a strut-based brachytherapy applicator for accelerated partial breast irradiation (APBI) offering tissue-sparing dosimetry and dose customization; and StatSeal Topical Hemostatic Sealant for hemostasis at wound sites. Together these address the localization, radiation-therapy, and post-procedural sealing stages of breast-cancer care. SCOUT's wire-free design represents a workflow improvement over traditional wire-guided localization, and the broader portfolio is positioned to deliver a more precise, patient-friendly surgical and radiation-oncology experience.

The company's revenue model is consistent with a regulated medical-device business: it sells FDA-cleared devices through clinical sales channels to hospitals, breast surgeons, and radiation oncologists, with no publicly disclosed pricing or contract structure. Prior to acquisition, Cianna had raised approximately $53.5M across seven venture rounds from 2008 to 2016, drawing institutional capital from GE Capital, Saints Capital, Novo Holdings/Novo Ventures, Fog City Capital, Emergent Medical Partners, BioLucent, and Windamere Venture Partners — signaling progressive clinical and commercial scaling of SCOUT and SAVI.

Cianna Medical was acquired by Merit Medical Systems (NASDAQ: MMSI), a publicly traded strategic operating company in interventional and oncology devices, and now operates as a subsidiary within Merit's oncology portfolio. Merit Medical maintains ISO 13485 certification for quality management in medical-device manufacturing. The acquisition gave Cianna's products access to Merit's global distribution network spanning more than 25 countries across North America, Europe, the Middle East, Asia-Pacific, Oceania, and South America, materially expanding the commercial footprint that Cianna could have achieved independently as an 11-50 employee organization.

Name

Cianna Medical

Legal name

Cianna Medical

Website

https://ciannamedical.com

Company type

Private

Founded year

2007

Operating status

Acquired

Headcount range

11–50 employees

Short description

Cianna Medical is a US medical-device company developing wire-free radar tumor localization (SCOUT), strut-based brachytherapy applicators (SAVI), and topical hemostatic sealants for early-stage breast cancer diagnosis and treatment, now operating as a subsidiary of Merit Medical Systems.

Ownership category

akta.pro rank

Product category

Breast Cancer Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Mammography & Breast Imaging Systems (HLAHABAF)

Keywords

• Breast cancer treatment
• Tumor localization devices
• Medical device manufacturing
• Radiation therapy applicators
• Women's health devices

Headquarters

HQ city

Aliso Viejo

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Core offering

Cianna Medical develops and commercializes medical devices for breast cancer diagnosis and treatment, with its flagship SCOUT Radar Localization System providing wire-free, radar-based tumor targeting for breast and soft tissue surgery. Following acquisition by Merit Medical Systems, the offering now spans complementary breast cancer care products including the SAVI Brachy applicator for accelerated partial breast irradiation and StatSeal Topical Hemostatic Sealant for wound hemostasis.

Product overview

The oncology portfolio offers a complementary set of products for breast cancer care: SAVI Brachy provides targeted accelerated partial breast irradiation (APBI) therapy using a strut-based applicator for precise dosimetry, while SCOUT Radar Localization enables wire-free tumor localization to guide surgeons during procedures. StatSeal Topical Hemostatic Sealant addresses hemostasis needs. Together, these products support a gentler, more precise approach to breast cancer diagnosis and treatment.

Differentiator

Problem solved

Functional benefit

Products and services

• SCOUT Radar Localization A wire-free radar-based tumor localization system that enables surgeons to precisely target affected tissue during breast and soft tissue procedures, designed to improve radiology workflow by decoupling placement from surgical scheduling.
• SAVI Brachy A strut-based brachytherapy applicator designed for accelerated partial breast irradiation (APBI), offering tissue-sparing dosimetry and dose customization for targeted breast cancer radiation treatment.
• StatSeal Topical Hemostatic Sealant A topical hemostatic sealant used to achieve hemostasis at wound sites, addressing bleeding control in surgical and wound care settings.

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Others

• BD (Becton Dickinson):

Broad incumbents

• Merit Medical Systems: Publicly-traded (NASDAQ: MMSI) parent company of Cianna Medical and developer of the SCOUT and SAVI Brachy products post-acquisition. Comparable as the strategic acquirer and oncology portfolio owner that now commercializes Cianna's technology globally.
• Varian Medical Systems (Siemens Healthineers): Global leader in radiation oncology hardware and software, including linear accelerators used in breast cancer radiotherapy. Adjacent competitor to Cianna's SAVI Brachy APBI platform, addressing overlapping radiation-oncology customers and budgets.
• Carl Zeiss Meditec: Provider of surgical microscopy and intraoperative imaging used in breast and oncologic surgery. Comparable as a vendor to the same surgical and breast-oncology institutions that purchase Cianna's SCOUT and SAVI products.
• Hologic: Major diversified breast-health company with a full mammography, biopsy, and specimen radiography portfolio. Highly comparable to Cianna as it directly competes in the breast-cancer care workflow that SCOUT and SAVI Brachy serve, with substantially greater scale.

Emerging players

• iCAD: Provider of AI-based breast cancer detection, density assessment, and treatment planning software. Comparable to Cianna as it serves the same breast-cancer imaging/radiology workflow customers, though its focus is software rather than interventional devices.
• Faxitron (Hologic): Provider of breast specimen radiography systems used intraoperatively during lumpectomy — directly complementary to the SCOUT workflow and increasingly bundled with broader breast-surgery platforms by competitors.

Direct peers

• Endomag (Hologic): Developer of the Magseed magnetic seed and Magtrace lymphatic tracer for wire-free breast lesion localization — the closest direct competitor to Cianna's SCOUT Radar Localization System. Acquired by Hologic, intensifying the competitive overlap with Cianna's flagship product.
• Mammotome (Danaher/Leica Biosystems): Breast biopsy and lesion localization systems widely used in breast-conserving surgery workflows. Comparable to Cianna because both target lesion localization and biopsy under ultrasound/stereotactic guidance in the same surgical and radiology customer base.
• Cianna SAVI Brachy competitors — Theragenics: Manufacturer of brachytherapy seeds and applicators used in radiation oncology, including breast brachytherapy. Directly competes with Cianna's SAVI Brachy accelerated partial breast irradiation (APBI) applicator in the same radiation-oncology customer segment.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/CiannaMedical
• Facebookfacebook.com/savisisters
• LinkedInlinkedin.com/company/320177

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds7 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cianna Medical